Overview
LGND market data
Price History
LGND price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for LGND. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Citigroup Reinstates Buy on Ligand Pharmaceuticals, Announces $387 Price TargetBenzinga · Jul 21, 2026, 7:00 PM
RBC Capital Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $340Benzinga · Jul 15, 2026, 3:57 PM
Why Is Agenus Stock Falling on Tuesday?Benzinga · Jul 14, 2026, 3:37 PM
Why Is Agenus Stock Gaining Monday?Benzinga · Jul 13, 2026, 3:29 PM
B of A Securities Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $388Benzinga · Jul 9, 2026, 11:35 AM
Stifel Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $332Benzinga · Jul 8, 2026, 1:40 PM
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool · Jul 6, 2026, 12:15 PM
Ligand Plans $550M Convertible Notes Offering, To Use Notes Sale for Share Buybacks and Corporate NeedsBenzinga · Jun 22, 2026, 11:15 AM
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record DateBenzinga · Jun 12, 2026, 9:15 PM
Ligand Announces 2026 Investor Day in New York CityGlobenewswire Inc · Jun 10, 2026, 11:15 AM